You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

nimotuzumab

Showing 1 - 25 of 69
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, EGFR Amplification Trial in Tianjin (Nimotuzumab)

Recruiting
  • Solid Tumor
  • EGFR Amplification
  • Nimotuzumab
  • Tianjin, Tianjin, China
    Tianjin Medical University Second Hospital
Aug 28, 2023

Esophageal Carcinoma Trial in Nanjing (Nimotuzumab, Tigio, Concurrent radiation therapy)

Enrolling by invitation
  • Esophageal Carcinoma
  • Nimotuzumab
  • +2 more
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital of Nanjing Medical University
Sep 19, 2023

Nasopharyngeal Carcinoma, Nasopharyngeal Tumors, Nasopharyngeal Diseases Trial in Guangzhou (Nimotuzumab, Cisplatin)

Recruiting
  • Nasopharyngeal Carcinoma
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 3, 2022

Penile Cancer Trial in Guangzhou (Albumin-Bound Paclitaxel, Ifosfamide, Cisplatin)

Completed
  • Penile Cancer
  • Albumin-Bound Paclitaxel
  • +4 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jun 8, 2022

Nasopharyngeal Carcinoma Trial in Shanghai (Camrelizumab, Nimotuzumab, neoadjuvant chemo and CCRT)

Recruiting
  • Nasopharyngeal Carcinoma
  • Shanghai, Shanghai, China
    Fudan Universtiy Shanghai Cancer Centre
Mar 6, 2023

Pancreatic Neuroendocrine Tumor Trial in Shanghai (Nimotuzumab)

Not yet recruiting
  • Pancreatic Neuroendocrine Neoplasm
  • Nimotuzumab
  • Shanghai, Shanghai, China
    Department of Pancreatic Surgery, Fudan University Shanghai Canc
Apr 4, 2022

Colorectal Cancer Trial in Nanjing, Beijing (Nimotuzumab, Irinotecan)

Completed
  • Colorectal Cancer
  • Nanjing, Jiangsu, China
  • +1 more
Mar 3, 2022

Nasopharyngeal Carcinoma by AJCC V8 Stage Trial in China (Nimotuzumab, Gemcitabine, Cisplatin)

Recruiting
  • Nasopharyngeal Carcinoma by AJCC V8 Stage
  • Nimotuzumab
  • +3 more
  • Baise, Guangxi, China
  • +8 more
Jan 29, 2023

Esophageal Trial in China (Nimotuzumab, Radiotherapy)

Completed
  • Esophageal
  • Nimotuzumab
  • Radiotherapy
  • Harbin, Heilongjiang, China
  • +4 more
Mar 3, 2022

Nimotuzumab in Combination With Chemoradiotherapy for LASCCHN

Recruiting
  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • nimotuzumab
  • Beijing, Beijing, China
  • +4 more
Mar 3, 2022

Esophageal Cancer, Chemoradiotherapy, Nimotuzumab Trial in Beijing (Radiotherapy, Nimotuzumab, S-1)

Recruiting
  • Esophageal Cancer
  • +3 more
  • Radiotherapy
  • +2 more
  • Beijing, China
    Department of Radiation Oncology, National Cancer Center/Nationa
Oct 21, 2021

Oral Squamous Cell Carcinoma Trial in Yichang (Nimotuzumab, Docetaxel, Carboplatin)

Recruiting
  • Oral Squamous Cell Carcinoma
  • Nimotuzumab
  • +2 more
  • Yichang, Hubei, China
    Department of Medical Oncology, Central Hospital of Yichang City
Nov 5, 2021

Cervical Squamous Cell Carcinoma Trial in Beijing (Nimotuzumab, EBRT combined with brachytherapy)

Not yet recruiting
  • Cervical Squamous Cell Carcinoma
  • Nimotuzumab
  • EBRT combined with brachytherapy
  • Beijing, Beijing, China
    Peking University 3rd Hospital
Jul 21, 2021

Head and Neck Squamous Cell Carcinoma Trial in China (Nimotuzumab)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Nimotuzumab
  • Hangzhou, China
  • +5 more
Aug 20, 2021

Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Trial (Nimotuzumab, Sintilimab, Chemotherapy drug)

Not yet recruiting
  • Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
  • Nimotuzumab
  • +2 more
  • (no location specified)
May 6, 2021

Carcinoma, Squamous Cell of Head and Neck Trial in Worldwide (Nimotuzumab, Placebo)

Active, not recruiting
  • Carcinoma, Squamous Cell of Head and Neck
  • Nimotuzumab
  • Placebo
  • Bedford Park, Australia
  • +29 more
Apr 4, 2022

Leptomeningeal Metastasis, Lung Cancer Trial in Hebei (Nimotuzumab)

Recruiting
  • Leptomeningeal Metastasis
  • Lung Cancer
  • Nimotuzumab
  • Hebei, Shijiazhuang/hebei, China
  • +1 more
Apr 18, 2021

Esophageal Cancer Trial in Beijing (Nimotuzumab)

Completed
  • Esophageal Cancer
  • Nimotuzumab
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Feb 2, 2021

Nasopharyngeal Carcinoma Trial in Beijin (Nimotuzumab, VMAT)

Recruiting
  • Nasopharyngeal Carcinoma
  • Nimotuzumab
  • VMAT
  • Beijin, China
    Cancer hospital, Chinese Academy of Medical Sciences
Jan 28, 2021

NSCLC Trial in Guangzhou (Avitinib Maleate, Afatinib, Crizotinib)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Avitinib Maleate
  • +13 more
  • Guangzhou, Guangdong, China
    Guangdong Lung Cancer Institute, Guangdong Provincial People's H
Dec 3, 2022

Non-small-cell Lung Cancer Trial in Guangzhou (Nimotuzumab, docetaxel and cisplatin, daily RT to the chest)

Completed
  • Non-small-cell Lung Cancer
  • Nimotuzumab
  • +2 more
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer Center
Feb 8, 2021

Cervical Squamous Cell Carcinoma Trial in Beijing (Nimotuzumab, Cisplatin, External-beam radiation)

Not yet recruiting
  • Cervical Squamous Cell Carcinoma
  • Nimotuzumab
  • +3 more
  • Beijing, Beijng, China
    Peking University 3rd Hospital
Dec 16, 2020

Esophagus Cancer, Esophagogastric Junction Cancer, Chemoradiation Trial in China (Radiotherapy, Platinum based chemo, Paclitaxel

Recruiting
  • Esophagus Cancer
  • +5 more
  • Radiotherapy
  • +5 more
  • Anyang, Henan, China
  • +4 more
Aug 17, 2022

Esophageal Cancer, Chemo Effect, Chemoradiation Trial in Beijing (drug, radiation, procedure)

Recruiting
  • Esophageal Cancer
  • +6 more
  • Platinum based chemotherapy
  • +6 more
  • Beijing, China
    Department of Radiation Oncology, National Cancer Center/Nationa
Mar 26, 2021

Diffuse Intrinsic Pontine Glioma Trial in Milan (Nimotuzumab, Vinorelbine, Radiotherapy)

Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Nimotuzumab
  • +2 more
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale Tumori
Sep 3, 2021